Navigation Links
Dynatronics Announces Fiscal Year 2008 Operating Results

Revenue Increases Offset by Charge for Goodwill Impairment

SALT LAKE CITY, Sept. 29 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced results for its fourth quarter and fiscal 2008 year-end periods.

Increased Revenues. As a result of acquisitions concluded in the fourth quarter of fiscal year 2007 and the first quarter of fiscal year 2008, the company recorded significant revenue increases for the fourth quarter and full fiscal year 2008. Sales for the fourth quarter ended June 30, 2008, increased 63 percent to $8,057,572, compared to $4,939,425 in the same quarter of the prior year. For the year ended June 30, 2008, sales increased 83 percent to $32,592,507, compared to $17,837,104 in fiscal year 2007. With the completion of the acquisition of six of the company's top independent distributors on June 30, 2007, and July 2, 2007, the company now has 36 direct sales reps covering 29 states across the country, in addition to a well-established dealer network.

"As we expected, in our first full year following the acquisitions, we nearly doubled our sales to approximately $32.6 million," stated Kelvyn H. Cullimore Jr., chairman and president of Dynatronics. "These acquisitions were critical and necessary steps in response to the changes that have been taking place in our industry. Unfortunately, the integration of these acquisitions took a few months longer than expected and the final integration costs were higher than projected."

Net Losses -- Impairment of Goodwill. Net loss for the quarter ended June 30, 2008, was $6,764,001 ($.50 per share), compared to a net income of $214,943 ($.02 per share) in the fourth quarter of the prior year. For the full fiscal year 2008, the company's net loss totaled $8,443,771 ($.62 per share), compared to a net loss of $85,042 ($.01 per share) in fiscal year 2007.

Included in the loss for the quarter and year ended June 30, 2008, is a charge of approximately $6.6 million related to the impairment of the company's goodwill assets. Applicable accounting standards require the company to impair its goodwill when the book value of the company's assets exceeds the market value of the company. The lower price of the company's stock on June 30, 2008 was the primary factor in triggering the impairment as the company's market capitalization dropped below its book value. Most of that goodwill was associated with the acquisitions in 2007 and 2008, as well as the 1996 acquisition of the company's Tennessee operations. This write-off is a non-cash adjustment.

Also included in the loss for fiscal year 2008 was more than $2 million in mostly acquisition related expenses related to the assimilation of the acquired dealers, including the expense of depleting acquired dealer inventories of Dynatronics products carried at wholesale cost rather than Dynatronics' manufactured cost base, reducing personnel and the associated severance costs, stock option expense, and duplicate SG&A overhead costs. In addition, the company recorded $768,000 of bad debt and inventory reserves during the year.

Excluding the $6.6 million goodwill impairment, the $2 million in mostly acquisition related expenses related to the assimilation of the acquired dealers and the $768,000 non-cash adjustments to bad debt and inventory reserves, the company showed an operating loss of approximately $500,000. We believe additional expense reductions subsequent to the fiscal year estimated to be over $250,000 annually should further improve operating results going forward.

Outlook for Fiscal Year 2009. "With the costs of assimilation now behind us and the impairment and other adjustments required by accounting rules booked, we believe that we are positioned to capitalize on the strategic plans we set in place last year," said Cullimore.

"Several factors are expected to help us become profitable," Cullimore continued. "Increased sales and improved margins will be key. The introduction of our first consolidated catalog in September 2008 is expected to give sales a strong boost going into the second quarter of the new fiscal year. In addition, a new pricing strategy is expected to improve margins. This includes the first price increase for our core products in over 20 years. The new catalog not only showcases more than 12,000 products, but facilitates a cohesive sales effort."

During fiscal year 2008, the company introduced the new Synergie Elite line of aesthetic products. "This is the first major redesign of Dynatronics' popular cellulite reduction and microdermabrasion devices, which should bring renewed interest to this high-margin product line," reported Kelvyn H. Cullimore Sr., vice chairman of Dynatronics.

With 36 direct sales representatives in 29 states, the company's presence of direct sales professionals continues to grow. "Over the coming year we will focus on bringing experienced distributors and dealers on board in areas where representation was lost through market consolidation," stated Larry K. Beardall, executive vice president of sales and marketing. "The focus of bringing on more dealers and sales representatives is expected to fuel additional growth in the next fiscal year."

During the process of assimilating its 2007-2008 acquisitions, the company consolidated eight distribution facilities into three distribution warehouses. This consolidation of facilities is expected to result in reductions in labor and overhead expenses in excess of $2.1 million annually.

Dynatronics has scheduled a conference call for investors on Monday, September 29, 2008, at 3:00 p.m. ET. Those wishing to participate should call 800-839-9416 and use passcode 9321818.

A summary of the financial results for the three and twelve months ended June 30, 2008, follows:

Summary Selected Financial Data

Statement of Operations Highlights

Three Months Ended Twelve Months Ended

June 30, June 30,

2008 2007 2008 2007

Net sales $8,057,572 $4,939,425 $32,592,507 $17,837,104

Cost of sales 5,022,123 2,761,875 20,450,570 10,925,316

Gross profit 3,035,449 2,177,550 12,141,937 6,911,788

SG&A expenses 3,232,380 1,603,167 13,473,190 5,541,860

R&D expenses 283,749 339,038 1,354,743 1,492,774

Goodwill impairment 6,636,466 - 6,636,466 -

Other expense, net 147,953 18,809 593,093 148,397

Net income (loss)

before income

taxes (7,265,099) 216,536 (9,915,555) (271,243)

Income tax expense

(benefit) (501,098) 1,593 (1,471,784) (186,201)

Net income

(loss) $(6,764,001) $214,943 $(8,443,771) $(85,042)

Net income (loss)

per share

(diluted) $(.50) $.02 $(.62) $(.01)

Balance Sheet Highlights

June 30, June 30,

2008 2007

Cash $288,481 $1,301,105

Accounts Receivable 5,151,235 3,757,484

Inventories 6,283,068 5,313,984

Total current assets 12,981,686 11,651,927

Total assets $18,427,819 $18,567,616

Accounts payable $1,423,839 $1,241,030

Accrued expenses 500,145 287,773

Line of credit 5,818,320 250,000

Total current liabilities 8,660,803 3,535,536

Total liabilities 12,162,180 7,496,972

Total liabilities and equity $18,427,819 $18,567,616

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at

This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, availability of financing at cost effective rates, and the risk factors listed from time to time in the company's SEC reports including, but not limited to, the report on Form 10-KSB for the year ended June 30, 2007, and its subsequent quarterly reports on Form 10-QSB. Forward-looking statements in this release include, but are not limited to all references to expected operating results in fiscal year 2009 under the caption "Outlook for Fiscal Year 2009."

SOURCE Dynatronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dynatronics to Release Fourth Quarter and Year-end Results Monday, September 29, 2008; Conference Call Set for 3:00 p.m. ET
2. Dynatronics Elects Mark A. Crockett to its Board of Directors
3. Dynatronics Receives NASDAQ Minimum Bid Price Deficiency Letter
4. Dynatronics Acquisitions Boost Sales 80 Percent in Third Quarter
5. Dynatronics to Release Third Quarter Results Wednesday, May 14, 2008; Conference Call Set for 2:30 p.m. ET
6. Dynatronics Reduces Annual Expenses by $1.9 Million
7. Dynatronics Introduces New DynaPro Spinal Health System and X5 Turbo
8. Dynatronics Introduces New Synergie Elite Aesthetic Line
9. Dynatronics Acquisitions Increase Sales 100 Percent in Second Quarter
10. Dynatronics to Release Second Quarter Results Thursday, February 14, 2008; Conference Call Set for 4:30 p.m. ET
11. Dynatronics Announces $250,000 Increase in Stock Buyback Program
Post Your Comments:
(Date:10/10/2015)... ... October 10, 2015 , ... Isabel Healthcare will participate in the Cerner Health ... the release of the Institute of Medicine’s latest report “Improving Diagnosis in Healthcare”, Isabel ... that assist healthcare providers and consumers to potentially reduce the chance of error. The ...
(Date:10/10/2015)... ... October 10, 2015 , ... In the inaugural people’s choice contest, entitled ... To Work in Jacksonville, amongst medium-sized companies with 25 – 99 employees. The announcement ... with a celebratory gala on October 1st. , Many of the features of ...
(Date:10/9/2015)... California (PRWEB) , ... October 09, 2015 , ... ... Osteopathic Medicine of the Pacific Associate Dean for Graduate Medical Education J. Michael ... of the Year Award. Finley was selected for his impact on graduate medical ...
(Date:10/9/2015)... Los Angeles, CA (PRWEB) , ... October 09, 2015 , ... ... awareness for breast cancer victims, survivors, and the ongoing effort to find a cure. ... patients another outlet for helping women in need. With their Bra Collection Campaign, Beverly ...
(Date:10/9/2015)... ... October 09, 2015 , ... A new health tool that helps identify if ... online ( ) – just in time for the cold and flu season, ... However, for many in the U.S., the real start of cold/flu season is the ...
Breaking Medicine News(10 mins):
... ... medical journal Osteoporosis International found that women taking AdvaCAL® calcium had the highest bone ... 32 studies involved 3,169 postmenopausal women, 79 skeletal measures and 7 different types of ... ...
... ... Dermatologist settled in Dubai, received the very prestigious ,HIND RATTAN AWARD, this ... Rattan was presented at a ceremony in connection with the yearly International ... Heavy Industries and Public Enterprises, Government of India. Dr. Mehta was awarded ...
... ... IL based management consulting and technology firm, today announced it will merge ... Gold Certified Partner, effective January 1, 2010. Logan Consulting is ... America, Europe and Asia since 1992. Under the new structure, ...
... , ... Omnetics Connector Corporation, the leading manufacturer of miniature high-rel connectors, is utilizing their ... , ... MN (Vocus) January 29, 2010 -- Omnetics Connector Corporation, the leading manufacturer of ...
... ... Vemma Nutrition Company launches Vemma ... or other sports drinks, Vemma THIRST goes beyond hydration by ... minerals, while replenishing the body with necessary electrolytes, specialized carbohydrates ...
... , , Majority of Mississippi ... Jan. 28 The following is a statement by ... Consumer Healthcare Products Association (CHPA): , "Today, the Mississippi ... that, if it becomes law, will greatly limit how cold and ...
Cached Medicine News:
(Date:10/8/2015)... , Oct. 8, 2015  Ardelyx, Inc. ... focused on gastrointestinal and cardio-renal diseases, today announced ... candidate, tenapanor, will be presented at the 2015 ... findings will include measures of sustained response in ... blind, placebo-controlled, randomized Phase 2 trial. The meeting ...
(Date:10/8/2015)...  Trovagene, Inc., (NASDAQ:   TROV) a developer ... of results from a field experience analysis featuring ... (PCM) platform to accurately identify mutational status, ... appropriate therapy for patients. Mark Erlander , ... the results today in an oral presentation titled ...
(Date:10/8/2015)... Oct. 8, 2015  Following months of investigation, Ross ... the nation alleging that the anticoagulant Xarelto,s recommended dosage doesn,t ... Philadelphia on behalf of a ... stroke because the drug didn,t work as the manufacturer suggested. ... other suits shortly on behalf of clients from across the ...
Breaking Medicine Technology:
... /PRNewswire/ --,Pieris AG, a bio-pharmaceutical company ... human protein therapeutics, announced today,that its ... targeting potential. , Commenting on this ... and Preclinical Development of Pieris said: ...
... NJ (June 21, 2007) Nymox Pharmaceutical,Corporation (NASDAQ: ... Company’s recently completed studies of NX-1207 for,benign ... a series of,upcoming U.S. urology meetings, beginning ... Association Meeting in Colorado,Springs. These independent podium ...
Cached Medicine Technology:
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: